Jenlab GmbH  

The company JenLab GmbH was founded at 1999 as an expert in the application of femto-seconds laser technology in the nano-biotechnology, pharmacology and medicine. The main product DermaInspect is the first Multiphoton tomograph for human skin. The system is useful for the melanoma research as well as for examinations of the skin ageing. Two other innovative products are the Laser scanning microscopes Femto-cut and TauMap for the visual transfektion and for the proof of protein-protein interactions. CEO Dr. Karsten Koenig. Dr. Karsten König.

Melanoma, Fluorescence lifetime Imaging, Aiging, Skin, multiphoton excitation, In situ drug monitoring, MiniCeM, Cosmetic, auto fluorescence, fluorescence imaging, Detection, MPTflex, Non invasive, Jenalab, multiphoton laser, Multiphoton tomography, Cancer research, Processing, Multiphoton, Nanosurgery, multiphoton microscopy, Bioinstrumentation, Femtocut, Skin cancer, SHG aging index dermis, Taumap, Cancer, Skin cancer detection, Research, Drug screening, Karsten König, SAAID, Koenig, FRET, Skin cancer diagnosis, Mikroskop, Hersteller, in vivo fluorescence imaging, Gentransfektion, Cell chamber, AF autofluorescence, Biotechnologieausrüstungen und zubehör, Gentransfection by femtosecond laser, Tomography, Skin research, imaging microscopy, Dermainspect, Femtogene, FLIM spectral imaging, König, Elektromedizinische Apparate, cosmetics resea, Biotechnologieunternehmen